FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046165793> ?p ?o ?g. }

• W2046165793 endingPage "247" @default.
• W2046165793 startingPage "241" @default.
• W2046165793 abstract "The data of the nationwide prospective registry of acute cerebral large vessel occlusion (LVO; RESCUE-Japan Registry) were analyzed to know the effect of edaravone, a free radical scavenger, on clinical outcome at 90 days after onset. In this registry, patients with acute cerebral LVO admitted within 24 h after onset were prospectively registered. The effect of various factors including endovascular treatment (EVT), intravenous recombinant tissue plasminogen activator (IV rt-PA), and other medication including edaravone on favorable outcome (modified Rankin scale 0–1) was analyzed. Of the 1,454 registered patients, 1,442 patients (99.2%) had the information of edaravone were analyzed. In total, edaravone group had more patients with favorable outcome compared to non-edaravone group (22.9% vs. 13.8%, p = 0.0006). Edaravone increased favorable outcome in patients treated with IV rt-PA (29.4% vs. 11.1%, p = 0.0107), but not with EVT (21.2% vs. 13.9%, p = 0.309). Logistic regression analysis revealed that higher National Institutes of Health Stroke Scale (NIHSS) score on admission [odds ratio (OR) 0.875, 95% confidence interval (CI) 0.858–0.894] and advanced age (OR 0.963, 95%CI 0.952–0.975) were significantly related to unfavorable outcome. In contrast, IV rt-PA (OR 2.489, 95%CI 1.867–3.319), EVT (OR 1.375, 95%CI 1.013–1.865), and edaravone (OR 1.483, 95%CI 1.027–2.143) were significantly associated with favorable outcome. This analysis indicated that IV rt-PA, EVT, and edaravone were effective to obtain favorable outcome in patients with acute LVO. Combination IV rt-PA with edaravone was more effective." @default.
• W2046165793 created "2016-06-24" @default.
• W2046165793 creator A5006006848 @default.
• W2046165793 creator A5007975779 @default.
• W2046165793 creator A5027959930 @default.
• W2046165793 creator A5036467430 @default.
• W2046165793 creator A5047400478 @default.
• W2046165793 creator A5071452719 @default.
• W2046165793 creator A5080104670 @default.
• W2046165793 creator A5086532298 @default.
• W2046165793 creator A5087288999 @default.
• W2046165793 date "2015-01-01" @default.
• W2046165793 modified "2023-10-04" @default.
• W2046165793 title "Effect of Edaravone on Favorable Outcome in Patients with Acute Cerebral Large Vessel Occlusion: Subanalysis of RESCUE-Japan Registry" @default.
• W2046165793 cites W195952512 @default.
• W2046165793 cites W1972753581 @default.
• W2046165793 cites W1993601145 @default.
• W2046165793 cites W1996802760 @default.
• W2046165793 cites W1997796302 @default.
• W2046165793 cites W2012072934 @default.
• W2046165793 cites W2014796100 @default.
• W2046165793 cites W2028398543 @default.
• W2046165793 cites W2032308540 @default.
• W2046165793 cites W2036653122 @default.
• W2046165793 cites W2082665716 @default.
• W2046165793 cites W2082794414 @default.
• W2046165793 cites W2101188164 @default.
• W2046165793 cites W2102447759 @default.
• W2046165793 cites W2111559905 @default.
• W2046165793 cites W2114603310 @default.
• W2046165793 cites W2116222748 @default.
• W2046165793 cites W2138411396 @default.
• W2046165793 cites W2142564261 @default.
• W2046165793 cites W2188308812 @default.
• W2046165793 cites W2464582673 @default.
• W2046165793 cites W2594075545 @default.
• W2046165793 cites W4234884688 @default.
• W2046165793 doi "https://doi.org/10.2176/nmc.ra.2014-0219" @default.
• W2046165793 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4533339" @default.
• W2046165793 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25739433" @default.
• W2046165793 hasPublicationYear "2015" @default.
• W2046165793 type Work @default.
• W2046165793 sameAs 2046165793 @default.
• W2046165793 citedByCount "37" @default.
• W2046165793 countsByYear W20461657932017 @default.
• W2046165793 countsByYear W20461657932018 @default.
• W2046165793 countsByYear W20461657932019 @default.
• W2046165793 countsByYear W20461657932020 @default.
• W2046165793 countsByYear W20461657932021 @default.
• W2046165793 countsByYear W20461657932022 @default.
• W2046165793 countsByYear W20461657932023 @default.
• W2046165793 crossrefType "journal-article" @default.
• W2046165793 hasAuthorship W2046165793A5006006848 @default.
• W2046165793 hasAuthorship W2046165793A5007975779 @default.
• W2046165793 hasAuthorship W2046165793A5027959930 @default.
• W2046165793 hasAuthorship W2046165793A5036467430 @default.
• W2046165793 hasAuthorship W2046165793A5047400478 @default.
• W2046165793 hasAuthorship W2046165793A5071452719 @default.
• W2046165793 hasAuthorship W2046165793A5080104670 @default.
• W2046165793 hasAuthorship W2046165793A5086532298 @default.
• W2046165793 hasAuthorship W2046165793A5087288999 @default.
• W2046165793 hasBestOaLocation W20461657931 @default.
• W2046165793 hasConcept C126322002 @default.
• W2046165793 hasConcept C141071460 @default.
• W2046165793 hasConcept C151956035 @default.
• W2046165793 hasConcept C156957248 @default.
• W2046165793 hasConcept C188816634 @default.
• W2046165793 hasConcept C2776151105 @default.
• W2046165793 hasConcept C2779554857 @default.
• W2046165793 hasConcept C2780931571 @default.
• W2046165793 hasConcept C2992339995 @default.
• W2046165793 hasConcept C3020199598 @default.
• W2046165793 hasConcept C44249647 @default.
• W2046165793 hasConcept C541997718 @default.
• W2046165793 hasConcept C71924100 @default.
• W2046165793 hasConceptScore W2046165793C126322002 @default.
• W2046165793 hasConceptScore W2046165793C141071460 @default.
• W2046165793 hasConceptScore W2046165793C151956035 @default.
• W2046165793 hasConceptScore W2046165793C156957248 @default.
• W2046165793 hasConceptScore W2046165793C188816634 @default.
• W2046165793 hasConceptScore W2046165793C2776151105 @default.
• W2046165793 hasConceptScore W2046165793C2779554857 @default.
• W2046165793 hasConceptScore W2046165793C2780931571 @default.
• W2046165793 hasConceptScore W2046165793C2992339995 @default.
• W2046165793 hasConceptScore W2046165793C3020199598 @default.
• W2046165793 hasConceptScore W2046165793C44249647 @default.
• W2046165793 hasConceptScore W2046165793C541997718 @default.
• W2046165793 hasConceptScore W2046165793C71924100 @default.
• W2046165793 hasIssue "3" @default.
• W2046165793 hasLocation W20461657931 @default.
• W2046165793 hasLocation W20461657932 @default.
• W2046165793 hasLocation W20461657933 @default.
• W2046165793 hasLocation W20461657934 @default.
• W2046165793 hasOpenAccess W2046165793 @default.
• W2046165793 hasPrimaryLocation W20461657931 @default.
• W2046165793 hasRelatedWork W2003263443 @default.
• W2046165793 hasRelatedWork W2037611947 @default.
• W2046165793 hasRelatedWork W2122595195 @default.

• next